Dramatic fall in number of clinical trials in Britain between 2017 and 2021
#medicalwriters #STEM #pharmaceutical

The ABPI notes a 44% drop in the number of participants recruited to commercial clinical trials in the past 5 years.

The number of industry clinical trials started in the same period fell by 41%.

As a result The Office for Life Sciences has announced there will be an independent review into the UK commercial clinical trials landscape by Lord James O’Shaughnessy, Senior Partner at consultancy firm Newmarket Strategy, Board Member of Health Data Research UK (HDR UK), and former Health Minister

The Office for Life Sciences is supposed to champion research, innovation and the use of technology to transform health and care service

Thanks to Paul Agapow on Twitter for the information.